We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » J&J to Start Largest Phase 3 Vaccine Trial Yet in September
J&J to Start Largest Phase 3 Vaccine Trial Yet in September
Johnson & Johnson (J&J) expects to begin the largest late-stage trial for a COVID-19 vaccine candidate to date early next month if results from its early-stage studies pan out.